Insiders · Profile

Chondros Dimitrios

SVP, Chief Medical Officer at HALOZYME THERAPEUTICS. Filing since 3 Aug 2019. CIK 0001739693

Company
Date
Role
Action
Shares
Amount
Of holding
3 Aug 2019
SVP, Chief Medical Officer
Sold, plan not stated
1,328
$22.18K
3.3%
1 decision on file.